Investigating Neurologic Improvement After IV Thrombolysis: The Effect of Time From Stroke Onset vs Imaging-Based Tissue Clock.
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
24 10 2023
24 10 2023
Historique:
received:
30
03
2023
accepted:
12
06
2023
pmc-release:
24
10
2024
medline:
6
11
2023
pubmed:
2
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
Time from stroke onset is associated with clinical response to intravenous thrombolysis (IVT) with alteplase and is therefore used to select patients for treatment. Alternatively, neuroimaging may be used for treatment in the uncertain or extended time window. We hypothesized that the patient-specific imaging indicator of ischemic lesion progression ("tissue clock") using CT perfusion (CTP) or quantitative net water uptake (NWU) is a predictor of early neurologic improvement (ENI) independent of time. Observational study of anterior circulation ischemic stroke patients with proximal vessel occlusion and known time from symptom onset triaged by multimodal CT undergoing endovascular treatment. Quantitative NWU using an established threshold (11.5%) or CTP lesion core mismatch (EXTEND criteria) was used to estimate ischemic lesion progression. The treatment effect of IVT depending on lesion progression defined by tissue clock vs time clock was assessed by inverse probability weighting (IPW). End points were binarized ENI and functional independence at day 90. Four hundred nine patients were included, of which 223 (54.5%) received IVT. The proportion of patients within an early time window (<4.5 hours), low NWU, and CTP mismatch were 45.0%, 86.5%, and 80.3%. In IPW, IVT was associated with higher rates of ENI (%-difference: 7.3%, CT-based measures of the "tissue clock" might identify patients who benefit from IVT more accurately than conventional time windows. Considering the high number of patients with early "tissue clock" (low NWU/CTP mismatch) within an extended time window, considerable benefit from IVT using imaging indicators of the "tissue clock" may be achieved.
Sections du résumé
BACKGROUND AND OBJECTIVES
Time from stroke onset is associated with clinical response to intravenous thrombolysis (IVT) with alteplase and is therefore used to select patients for treatment. Alternatively, neuroimaging may be used for treatment in the uncertain or extended time window. We hypothesized that the patient-specific imaging indicator of ischemic lesion progression ("tissue clock") using CT perfusion (CTP) or quantitative net water uptake (NWU) is a predictor of early neurologic improvement (ENI) independent of time.
METHODS
Observational study of anterior circulation ischemic stroke patients with proximal vessel occlusion and known time from symptom onset triaged by multimodal CT undergoing endovascular treatment. Quantitative NWU using an established threshold (11.5%) or CTP lesion core mismatch (EXTEND criteria) was used to estimate ischemic lesion progression. The treatment effect of IVT depending on lesion progression defined by tissue clock vs time clock was assessed by inverse probability weighting (IPW). End points were binarized ENI and functional independence at day 90.
RESULTS
Four hundred nine patients were included, of which 223 (54.5%) received IVT. The proportion of patients within an early time window (<4.5 hours), low NWU, and CTP mismatch were 45.0%, 86.5%, and 80.3%. In IPW, IVT was associated with higher rates of ENI (%-difference: 7.3%,
DISCUSSION
CT-based measures of the "tissue clock" might identify patients who benefit from IVT more accurately than conventional time windows. Considering the high number of patients with early "tissue clock" (low NWU/CTP mismatch) within an extended time window, considerable benefit from IVT using imaging indicators of the "tissue clock" may be achieved.
Identifiants
pubmed: 37657940
pii: WNL.0000000000207714
doi: 10.1212/WNL.0000000000207714
pmc: PMC10624495
doi:
Substances chimiques
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1678-e1686Informations de copyright
© 2023 American Academy of Neurology.
Références
J Neurol Neurosurg Psychiatry. 2022 May 16;:
pubmed: 35577509
JAMA. 1995 Oct 4;274(13):1017-25
pubmed: 7563451
Clin Neuroradiol. 2022 Sep;32(3):839-847
pubmed: 35244728
Int J Stroke. 2019 Jan;14(1):87-93
pubmed: 30156479
Int J Stroke. 2021 Aug;16(6):621-631
pubmed: 34003709
Transl Stroke Res. 2023 Aug;14(4):562-571
pubmed: 35778671
Clin Neuroradiol. 2022 Dec;32(4):997-1009
pubmed: 35622100
J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):903-909
pubmed: 29519900
N Engl J Med. 2023 Apr 6;388(14):1259-1271
pubmed: 36762865
Lancet. 1998 Oct 17;352(9136):1245-51
pubmed: 9788453
Eur Stroke J. 2021 Mar;6(1):I-LXII
pubmed: 33817340
N Engl J Med. 2019 May 9;380(19):1795-1803
pubmed: 31067369
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1055-1059
pubmed: 32934109
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Stroke. 2016 Sep;47(9):2373-9
pubmed: 27507856
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Stroke. 2021 May;52(5):1847-1850
pubmed: 33813863
Ann Neurol. 2016 Dec;80(6):924-934
pubmed: 28001316
Eur Radiol. 2022 Aug;32(8):5517-5524
pubmed: 35278122
Sci Rep. 2022 Nov 29;12(1):20567
pubmed: 36446862
Neurology. 2023 Feb 28;100(9):e954-e963
pubmed: 36414425
Stroke. 2004 Sep;35(9):2099-104
pubmed: 15272132
Lancet Neurol. 2018 Oct;17(10):895-904
pubmed: 30264728
Stroke. 2022 Jan;53(1):201-209
pubmed: 34538082
Interv Neurol. 2020 Feb;8(1):55-59
pubmed: 32231695
Stroke. 2020 Apr;51(4):1226-1230
pubmed: 32102629
Eur J Neurol. 2022 Nov;29(11):3264-3272
pubmed: 35808904
J Neurointerv Surg. 2022 Mar;14(3):209
pubmed: 35115395
Invest Radiol. 2018 Apr;53(4):207-213
pubmed: 29200013
Stroke. 2019 Dec;50(12):3424-3430
pubmed: 31665994
Stroke. 2019 Aug;50(8):2238-2240
pubmed: 31203787
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Int J Stroke. 2021 Oct;16(7):863-872
pubmed: 31657283
Ann Neurol. 2020 Dec;88(6):1144-1152
pubmed: 32939824
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Stroke. 2017 Sep;48(9):2621-2627
pubmed: 28794271
Eur Stroke J. 2019 Mar;4(1):6-12
pubmed: 31165090